Innospec (IOSP) Director Hugh Aldous Sells 1,687 Shares

Innospec (NASDAQ:IOSP) Director Hugh Aldous sold 1,687 shares of the stock in a transaction dated Tuesday, May 22nd. The shares were sold at an average price of $76.72, for a total transaction of $129,426.64. Following the completion of the sale, the director now owns 20,705 shares of the company’s stock, valued at approximately $1,588,487.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Innospec traded down $0.25, reaching $76.00, during midday trading on Wednesday, according to Marketbeat. 2 shares of the company’s stock were exchanged, compared to its average volume of 123,557. The stock has a market cap of $1.87 billion, a price-to-earnings ratio of 16.33 and a beta of 1.03. The company has a quick ratio of 1.28, a current ratio of 2.13 and a debt-to-equity ratio of 0.24. Innospec has a one year low of $54.10 and a one year high of $79.90.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings results on Tuesday, May 8th. The specialty chemicals company reported $1.02 EPS for the quarter, topping analysts’ consensus estimates of $0.91 by $0.11. The firm had revenue of $360.70 million during the quarter, compared to analysts’ expectations of $308.90 million. Innospec had a net margin of 4.86% and a return on equity of 14.91%. The company’s revenue for the quarter was up 22.6% compared to the same quarter last year. During the same quarter last year, the company earned $1.00 earnings per share. equities research analysts expect that Innospec will post 4.4 EPS for the current fiscal year.

The company also recently disclosed a semiannual dividend, which will be paid on Thursday, May 31st. Stockholders of record on Monday, May 21st will be issued a dividend of $0.44 per share. This is a positive change from Innospec’s previous semiannual dividend of $0.39. The ex-dividend date is Friday, May 18th. This represents a dividend yield of 1.18%. Innospec’s dividend payout ratio (DPR) is presently 37.77%.

Several equities research analysts recently weighed in on the stock. ValuEngine upgraded shares of Innospec from a “hold” rating to a “buy” rating in a research note on Thursday, March 1st. BidaskClub upgraded shares of Innospec from a “hold” rating to a “buy” rating in a research note on Thursday, April 19th. Johnson Rice upgraded shares of Innospec from an “accumulate” rating to a “buy” rating in a research note on Tuesday, April 24th. Finally, Zacks Investment Research upgraded shares of Innospec from a “sell” rating to a “hold” rating in a research note on Thursday, April 19th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $75.00.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Legal & General Group Plc increased its holdings in shares of Innospec by 2.7% in the first quarter. Legal & General Group Plc now owns 49,645 shares of the specialty chemicals company’s stock valued at $3,399,000 after purchasing an additional 1,312 shares in the last quarter. Barclays PLC increased its holdings in shares of Innospec by 19.0% in the first quarter. Barclays PLC now owns 8,572 shares of the specialty chemicals company’s stock valued at $588,000 after purchasing an additional 1,367 shares in the last quarter. UBS Group AG increased its holdings in shares of Innospec by 69.3% in the first quarter. UBS Group AG now owns 2,771 shares of the specialty chemicals company’s stock valued at $190,000 after purchasing an additional 1,134 shares in the last quarter. Westwood Holdings Group Inc. increased its holdings in shares of Innospec by 8.4% in the first quarter. Westwood Holdings Group Inc. now owns 398,922 shares of the specialty chemicals company’s stock valued at $27,366,000 after purchasing an additional 30,850 shares in the last quarter. Finally, Profund Advisors LLC increased its holdings in shares of Innospec by 21.4% in the first quarter. Profund Advisors LLC now owns 4,452 shares of the specialty chemicals company’s stock valued at $305,000 after purchasing an additional 786 shares in the last quarter. 91.80% of the stock is owned by institutional investors.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals for use as fuel additives, ingredients for personal care, home care, agrochemical, mining and other applications, and oilfield chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives.

Insider Buying and Selling by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply